BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Holistic medicine
,
Fluoxetine
,
rs3825942
,
FXYD4
,
Metabolism of xenobiotics
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PI 3 kinase
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
Treated keratinocyte HaCaT cell line overexpressing EGFR, RELA (p65), or HRAS-VAL12D
Erythroblasts of fetal mouse livers with Plek2 shRNA-knockdown
Functional relevance of tetraspanin CD9 in vascular smooth muscle cell injury
Monocyte motility and resulting viral spread after human cytomegalovirus infection
Explore Curated Studies Results
Literature
Most Relevant Literature
Anti-apoptotic Effect of MiR-223-3p Suppressing PIK3C2A in Cardiomyocytes from Myocardial Infarction…
PI3KC2α-dependent and VPS34-independent generation of PI3P controls primary cilium-mediated autophag…
Lipid kinase PIK3C3 maintains healthy brown and white adipose tissues to prevent metabolic diseases.
Dendritic cell PIK3C3/VPS34 controls the pathogenicity of CNS autoimmunity independently of LC3-asso…
Arsenic induces dysfunctional autophagy via dual regulation of mTOR pathway and Beclin1-Vps34/PI3K c…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway Gen…
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors
Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma
Adaptive COVID-19 Treatment Trial 3 (ACTT-3)
Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Mu…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ